Therapeutic potential of serotonin antagonists in depressive disorders

Author： Thomas David R Watson Jeannette M Wood Martyn D

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.4, 2002-04, pp. : 457-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. : 357-368

Bentham Science Publishers

Access to resources Recommend Favorite

Corticotropin-Releasing Factor Antagonists: Therapeutic Potential in the Treatment of Affective Disorders

By Owens M.J. Nemeroff C.B.

CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan Guglin Maya Vaitkevicius Peter Ghali Jalal K.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite